Apnimed
- Biotech or pharma, therapeutic R&D
Apnimed is a clinical-stage (P3) pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from a safe and effective oral medication dosed once daily at bedtime
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}